Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Inventory (2016 - 2025)

STRATA Skin Sciences' Inventory history spans 14 years, with the latest figure at $2.8 million for Q4 2025.

  • On a quarterly basis, Inventory rose 25.29% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 25.29% increase, with the full-year FY2025 number at $2.8 million, up 25.29% from a year prior.
  • Inventory hit $2.8 million in Q4 2025 for STRATA Skin Sciences, down from $3.1 million in the prior quarter.
  • Over the last five years, Inventory for SSKN hit a ceiling of $6.1 million in Q3 2023 and a floor of $2.2 million in Q4 2024.
  • Historically, Inventory has averaged $3.7 million across 5 years, with a median of $3.2 million in 2021.
  • Biggest five-year swings in Inventory: surged 75.57% in 2022 and later plummeted 55.2% in 2024.
  • Tracing SSKN's Inventory over 5 years: stood at $3.5 million in 2021, then decreased by 11.29% to $3.1 million in 2022, then fell by 13.63% to $2.7 million in 2023, then dropped by 15.97% to $2.2 million in 2024, then rose by 25.29% to $2.8 million in 2025.
  • Business Quant data shows Inventory for SSKN at $2.8 million in Q4 2025, $3.1 million in Q3 2025, and $3.2 million in Q2 2025.